Trimetazidine Dihydrochloride Modified Release 35 Mg Tablets

Trimetazidine Dihydrochloride Modified Release 35 Mg Tablets

Trimetazidine Dihydrochloride Modified Release 35 Mg Tablets are a specialized medication used in the treatment of angina pectoris and heart disease. Trimetazidine works by optimizing cellular metabolism in the heart muscle, improving its efficiency and reducing symptoms of angina. This medication provides significant support in managing cardiovascular conditions, ensuring better quality of life for patients.

Key Ingredients:

Trimetazidine Dihydrochloride (35 mg): A metabolic agent that enhances myocardial glucose utilization through inhibition of fatty acid oxidation, thereby preserving cellular function and improving cardiac performance.

Product Features:

Angina Management: Reduces the frequency and severity of angina attacks by improving myocardial energy metabolism.

Enhances Cardiac Function: Optimizes heart muscle efficiency, leading to better tolerance of physical exertion.

Improves Quality of Life: Helps patients maintain an active lifestyle with reduced angina symptoms.